Nephrotic Syndrome and Vasculitis After SARS-CoV-2 Vaccine Nephrotic Syndrome and Vasculitis After SARS-CoV-2 Vaccine
Are reported cases of nephrotic syndrome and vasculitis associated with the administration of the COVID-19 vaccine?Nephrology Dialysis Transplantation (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - September 17, 2021 Category: Intensive Care Tags: Nephrology Journal Article Source Type: news

What Are the Advantages and Disadvantages of Different Renal Replacement Therapies?
Discussion Kidneys are amazing in that they filter the blood, eliminate toxins, balance fluids and electrolytes plus have a lot of reserve to do the job they need to do even when injured. Therefore, depending on the problem, chronic renal disease (CRD) often allows time before renal replacement therapy (RRT) is needed. RRT currently is dialysis (peritoneal or hemodialysis) or renal transplant. In general, the patient’s own kidneys do the best job for them but there is always a balance between the problems of CRD and its management, versus the potentially improved renal function with RRT. RRT itself though has a diffe...
Source: PediatricEducation.org - September 13, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Kidney Patients Get Palliative Care, Dialysis'Til the End Kidney Patients Get Palliative Care, Dialysis'Til the End
Seattle's Northwest Kidney Centers, which pioneered kidney failure treatment 50 years ago, now pairs dying patients with hospice services without forcing them to forgo the comfort dialysis can provide.Kaiser Health News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 31, 2021 Category: Consumer Health News Tags: Nephrology News Source Type: news

FDA Okays Difelikefalin for Dialysis-Associated Pruritus in CKD FDA Okays Difelikefalin for Dialysis-Associated Pruritus in CKD
Reactions to the approval of difelikefalin for dialysis-associated pruritus are mixed, with some nephrologists questioning the weight of the evidence.FDA Approvals (Source: Medscape Dermatology Headlines)
Source: Medscape Dermatology Headlines - August 27, 2021 Category: Dermatology Tags: Nephrology News Alert Source Type: news

Roxadustat Treats Anemia in Non - Dialysis - Dependent CKD
Pooled data show roxadustat versus placebo increases hemoglobin levels with an acceptable profile for cardiovascular safety (Source: The Doctors Lounge - Oncology)
Source: The Doctors Lounge - Oncology - August 23, 2021 Category: Cancer & Oncology Tags: Cardiology, Internal Medicine, Nephrology, Oncology, Pharmacy, Journal, Source Type: news

Roxadustat Treats Anemia in Non-Dialysis-Dependent CKD
MONDAY, Aug. 23, 2021 -- For patients with non-dialysis-dependent chronic kidney disease (CKD) and CKD-related anemia, roxadustat increases hemoglobin levels and reduces the need for red blood cell transfusions, according to a study published in the... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - August 23, 2021 Category: Pharmaceuticals Source Type: news

Patients on Dialysis Need mRNA COVID Booster Shot: UK Study Patients on Dialysis Need mRNA COVID Booster Shot: UK Study
Patients on hemodialysis in the UK should be prioritized to get a booster (third dose) of an mRNA vaccine if they had no prior COVID-19 and received two doses of the Oxford AstraZeneca vaccine.Medscape Medical News (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - August 20, 2021 Category: Intensive Care Tags: Nephrology News Source Type: news

Benefits and Risks of Frequent or Longer Hemodialysis Benefits and Risks of Frequent or Longer Hemodialysis
What are the effects of more frequent or longer hemodialysis? A new review looks at the benefits and risks.Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - August 16, 2021 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Local health care organizations team up to build dialysis clinic in Honolulu
“This new center will provide more convenience for patients and their families,” said Jason Chang, COO at The Queen’s Health Systems, in a statement. (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - August 12, 2021 Category: Biotechnology Authors: Kelsey Kukaua Source Type: news

Local health care organizations team up to build dialysis clinic in Honolulu
“This new center will provide more convenience for patients and their families,” said Jason Chang, COO at The Queen’s Health Systems, in a statement. (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - August 12, 2021 Category: American Health Authors: Kelsey Kukaua Source Type: news

Artificial Pancreas Tried in Type 2 Diabetes Patients on Dialysis Artificial Pancreas Tried in Type 2 Diabetes Patients on Dialysis
Artificial pancreas system improved glucose control and reduced hypoglycemia in adults with type 2 diabetes requiring dialysis. (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - August 6, 2021 Category: Transplant Surgery Tags: Diabetes & Endocrinology News Source Type: news

FDA Rejects Tenapanor for Control of Phosphorus in Kidney Disease FDA Rejects Tenapanor for Control of Phosphorus in Kidney Disease
An additional trial showing a'clinically relevant treatment effect'needed for approval in patients with kidney disease on dialysis, says the FDA in response to a new drug application.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - August 5, 2021 Category: Consumer Health News Tags: Nephrology News Source Type: news

Challenge of Implementing Sustained Sodium Reductions in CKD Challenge of Implementing Sustained Sodium Reductions in CKD
Reducing sodium intake is important for those with chronic kidney disease, so why is implementing these recommendations so difficult?Nephrology Dialysis Transplantation (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - August 2, 2021 Category: Transplant Surgery Tags: Nephrology Journal Article Source Type: news

Additional NHS support to cover cost of hospital travel
Every patient who needs kidney dialysis will benefit from free transport to and from vital hospital appointments. (Source: NHS Networks)
Source: NHS Networks - August 2, 2021 Category: UK Health Source Type: news

Ardelyx Receives Complete Response Letter from U.S. FDA for New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis
FREMONT, Calif. and WALTHAM, Mass., July 29, 2021 /PRNewswire/ -- Ardelyx Inc.,(Nasdaq: ARDX), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative first-in-class medicines... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - July 29, 2021 Category: Drugs & Pharmacology Source Type: news

Vitamin-C Induced Hyperglycemia in a Dialysis Patient Vitamin-C Induced Hyperglycemia in a Dialysis Patient
High-dose vitamin C is increasingly used for sepsis and recently for treating COVID-19, but the adverse effects of this treatment in vulnerable patients may be underreported, as seen in this case.Journal of Medical Case Reports (Source: Medscape Critical Care Headlines)
Source: Medscape Critical Care Headlines - July 22, 2021 Category: Intensive Care Tags: Nephrology Journal Article Source Type: news

A Fremont drug maker's stock tumbled 76% after the FDA dissed its kidney drug
Ardelyx Inc.'s attempt to win a second drug approval was beat back by federal regulators, sending its stock down as much as 76% Tuesday. The Fremont company (NASDAQ: ARDX) had hoped to win Food and Drug Administration approval for tenapanor as a treatment for hyperphosphatemia, a life-threatening surge of phosphates in the blood of adult chronic kidney disease patients on dialysis. But Ardelyx revealed Monday that it received a let ter from the FDA on July 13 identifying "deficiencies" in its approval… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 20, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

A Fremont drug maker's stock tumbled 76% after the FDA dissed its kidney drug
Ardelyx Inc.'s attempt to win a second drug approval was beat back by federal regulators, sending its stock down as much as 76% Tuesday. The Fremont company (NASDAQ: ARDX) had hoped to win Food and Drug Administration approval for tenapanor as a treatment for hyperphosphatemia, a life-threatening surge of phosphates in the blood of adult chronic kidney disease patients on dialysis. But Ardelyx revealed Monday that it received a let ter from the FDA on July 13 identifying "deficiencies" in its approval… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 20, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

East Bay drug maker tumbles 76% after FDA disses kidney drug
Ardelyx Inc.'s attempt to win a second drug approval was beat back by federal regulators, sending its stock down as much as 76% Tuesday. The Fremont company (NASDAQ: ARDX) had hoped to win Food and Drug Administration approval for tenapanor as a treatment for hyperphosphatemia, a life-threatening surge of phosphates in the blood of adult chronic kidney disease patients on dialysis. But Ardelyx revealed Monday that it received a let ter from the FDA on July 13 identifying "deficiencies" in the company's… (Source: bizjournals.com Health Care:Pharmaceuticals headlines)
Source: bizjournals.com Health Care:Pharmaceuticals headlines - July 20, 2021 Category: Pharmaceuticals Authors: Ron Leuty Source Type: news

East Bay drug maker tumbles 76% after FDA disses kidney drug
Ardelyx Inc.'s attempt to win a second drug approval was beat back by federal regulators, sending its stock down as much as 76% Tuesday. The Fremont company (NASDAQ: ARDX) had hoped to win Food and Drug Administration approval for tenapanor as a treatment for hyperphosphatemia, a life-threatening surge of phosphates in the blood of adult chronic kidney disease patients on dialysis. But Ardelyx revealed Monday that it received a let ter from the FDA on July 13 identifying "deficiencies" in the company's… (Source: bizjournals.com Health Care:Biotechnology headlines)
Source: bizjournals.com Health Care:Biotechnology headlines - July 20, 2021 Category: Biotechnology Authors: Ron Leuty Source Type: news

Ardelyx Provides Regulatory Update on New Drug Application for Tenapanor for the Control of Serum Phosphorus in Adult Patients with CKD on Dialysis
FREMONT, Calif. and WALTHAM, Mass., July 19, 2021 /PRNewswire/ -- Ardelyx, Inc. (Nasdaq: ARDX), a biopharmaceutical company focused on the discovery, development, and commercialization of innovative first-in-class... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - July 19, 2021 Category: Drugs & Pharmacology Source Type: news

New guidance on how to diagnosis and manage osteoporosis in chronic kidney disease
(International Osteoporosis Foundation) This new review by the International Osteoporosis Foundation (IOF) and European Renal Association-European Dialysis and Transplant Association (ERA-EDTA) CKD-MBD working group provides concise recommendations, with a clear management algorithm, to support clinicians' knowledge and confidence in managing osteoporosis in their patients with chronic kidney disease stages 4-5D. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 15, 2021 Category: International Medicine & Public Health Source Type: news

Home and Facility Hemodialysis Patients Home and Facility Hemodialysis Patients
How do the outcomes of patients on home hemodialysis compare with that of facility dialysis patients?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 14, 2021 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Around 20% of dialysis patients in American contracted COVID-19 at some point last year
Dialysis patients are not at an increased risk to have contracted COVID-19 last year, according to a study. The demographics of dialysis patients who contract COVID also match the U.S. population. (Source: the Mail online | Health)
Source: the Mail online | Health - July 13, 2021 Category: Consumer Health News Source Type: news

Do more visits with kidney specialists improve dialysis patient-reported outcomes?
(American Society of Nephrology) Patients with kidney failure did not report better experience with care from more frequent face-to-face visits with kidney specialists at dialysis facilities. In fact, more frequent visits were linked with slightly lower patient-reported experiences with kidney-related care. (Source: EurekAlert! - Medicine and Health)
Source: EurekAlert! - Medicine and Health - July 12, 2021 Category: International Medicine & Public Health Source Type: news

CMS: Medicare Program; End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals With Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model
Notice of a proposed rule from the Centers for Medicare and Medicaid Services (CMS) making changes related to End-Stage Renal Disease (ESRD) payments for calendar year 2022 and proposing updates to the payment rate for renal dialysis services furnished by an ESRD facility to individuals with acute kidney injury (AKI). Also includes proposed updated requirements for the Quality Incentive Program (QIP), among other things. Comments on the proposed rule are due August 31, 2021. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - July 9, 2021 Category: Rural Health Source Type: news

The Role of Activin: The Other Side of CKD-MBD? The Role of Activin: The Other Side of CKD-MBD?
A new review explores the potential role of activin A in the development of mineral bone disorder in patients with chronic kidney disease.Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - July 7, 2021 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Four cases of acute renal injury caused by acute dimethyl oxalate poisoning - Shao JJ, Xu QL, Yao SL, Yang YR, Liu XY.
OBJECTIVE: To investigate the clinical features, non-dialysis treatment and prognosis of acute renal injury caused by acute dimethyl oxalate (DMO) poisoning. METHODS: Retrospective analysis was performed on the occupational data, clinical manifesta... (Source: SafetyLit)
Source: SafetyLit - July 6, 2021 Category: International Medicine & Public Health Tags: Occupational Issues Source Type: news

Critical tetramine poisoning after sea snail ingestion in a patient on peritoneal dialysis: a case report - Yeo IH, Lim JH.
Tetramine in gastropods can cause poisoning symptoms with various side effects. Most of these symptoms are mild and spontaneously resolved due to the rapid excretion of tetramine through the kidneys; however, patients with kidney dysfunction can present se... (Source: SafetyLit)
Source: SafetyLit - July 5, 2021 Category: International Medicine & Public Health Tags: Economics of Injury and Safety, PTSD, Injury Outcomes Source Type: news

What Problems are Ciliopathies Associated With?
Discussion Nephronophthisis (NPHP) one cause of end-stage renal disease (ESRD) usually occurring before age 30 years. NPHP is a non-motile ciliopathy affecting cellular sensing in the renal tubular epithelium. See To Learn More below. The incidence varies according to location with 1:1 million in the US but 1:50,000 in Finland. There are 3 subtypes: Infantile Occurs usually within 1 year of life Enlarged kidneys and severe hypertension In utero can have oligohydramnios problems such as pulmonary hypoplasia, facial dysmorphisms, limb contractures Extra-renal problems include congenital heart disease, liver fibrosis, recur...
Source: PediatricEducation.org - July 5, 2021 Category: Pediatrics Authors: Pediatric Education Tags: Uncategorized Source Type: news

Novel Liver Dialysis Device May Safely Curb ACLF Novel Liver Dialysis Device May Safely Curb ACLF
The investigational DIALIVE liver dialysis system removes and replaces albumin and filters endotoxins in patients with acute-on-chronic liver failure.Medscape Medical News (Source: Medscape Transplantation Headlines)
Source: Medscape Transplantation Headlines - July 2, 2021 Category: Transplant Surgery Tags: Gastroenterology News Source Type: news

Public Inspection: CMS: Medicare Program: End-Stage Renal Disease Prospective Payment System, Payment for Renal Dialysis Services Furnished to Individuals with Acute Kidney Injury, End-Stage Renal Disease Quality Incentive Program, and End-Stage Renal Disease Treatment Choices Model
Pre-publication notice of a proposed rule from the Centers for Medicare and Medicaid Services (CMS) making changes related to End-Stage Renal Disease (ESRD) payments for calendar year 2022 and proposing updates to the payment rate for renal dialysis services furnished by an ESRD facility to individuals with acute kidney injury (AKI). Also includes proposed updated requirements for the Quality Incentive Program (QIP), among other things. Comments on the proposed rule are due August 31, 2021. (Source: Federal Register updates via the Rural Assistance Center)
Source: Federal Register updates via the Rural Assistance Center - July 2, 2021 Category: Rural Health Source Type: news

Fenofibrate Delays Dialysis Need and Reduces CV Risk in CKD Fenofibrate Delays Dialysis Need and Reduces CV Risk in CKD
A new study examines the beneficial effects of fenofibrate in reducing CV risk and dialysis need among advanced CKD patients.Journal of Clinical Endocrinology & Metabolism (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 28, 2021 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

real-world-benefit-shown-in-T2D-treatment
Empagliflozin reduced the risk of cardiovascular events and hospitalization for heart failure compared to DPP-4 inhibitors in people with type 2 diabetes  Interim analysis of the EMPRISE real-world evidence study showed that empagliflozin was associated with a reduced risk in all-cause mortality, hospitalization for heart failure and acute kidney injury requiring dialysis, compared to DPP-4 inhibitorsThis analysis, which includes European data pooled with data from Israel and East Asia, was presented for the first time at the American Diabetes Association Scientific Sessions, 25 June 20211  EMPRISE data complemen...
Source: Boehringer Ingelheim Corporate News - June 28, 2021 Category: Research Source Type: news

Quanta scores $245M to improve dialysis care, AlayaCare closes $225M Series D to expand home healthcare offerings and more digital health fundings
Also: JMI Equity invests in Greenlight Guru, Adela launches with $60 million and Bicycle Health tackles opioid use disorder with $27 million in new capital.     (Source: mobihealthnews)
Source: mobihealthnews - June 24, 2021 Category: Information Technology Source Type: news

Controlling Pain in Dialysis Care Controlling Pain in Dialysis Care
Nonsteroidal anti-inflammatory drugs are commonly recommended for pain management in dialysis patients, but risks for drug-related adverse events are a concern.Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - June 23, 2021 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news

Dialysis device maker raises $245M for U.S. expansion
Dialysis device maker Quanta Dialysis Technologies Ltd. is gearing up to expand in Massachusetts after a $245 million round — the largest-ever private funding round for a dialysis device company, Quanta says. Headquartered in the U.K., Quanta plans to "escalate" its growth stateside over the next year. The company opened its U.S. office and service center in Beverly about six months ago and has since secured 510(k) cl earance from the U.S. Food and Drug Administration for SC+, its kidney dialysis… (Source: bizjournals.com Health Care:Physician Practices headlines)
Source: bizjournals.com Health Care:Physician Practices headlines - June 23, 2021 Category: American Health Authors: Rowan Walrath Source Type: news

Guidelines Updated for Managing BP in CKD Patients Not on Dialysis
TUESDAY, June 22, 2021 -- For patients with high blood pressure (BP) and chronic kidney disease (CKD) who are not receiving dialysis, a systolic BP of
Source: Drugs.com - Pharma News - June 22, 2021 Category: Pharmaceuticals Source Type: news

No more kidney dialysis? Lebanese hospitals issue warning
Hospitals in Lebanon are warning that they may be forced to suspend kidney dialysis amid severe shortages in supplies (Source: ABC News: Health)
Source: ABC News: Health - June 10, 2021 Category: Consumer Health News Tags: Health Source Type: news

Medicare's Penalties for Poor-Quality Dialysis Centers Aren't Helping: Study
Title: Medicare's Penalties for Poor-Quality Dialysis Centers Aren't Helping: StudyCategory: Health NewsCreated: 6/9/2021 12:00:00 AMLast Editorial Review: 6/10/2021 12:00:00 AM (Source: MedicineNet Digestion General)
Source: MedicineNet Digestion General - June 10, 2021 Category: Nutrition Source Type: news

Just 18% of people who have had kidney transplants develop antibody responses to COVID-19 vaccines
A new study from Rouen Hospital in France found that after two doses of Pfizer's vaccine, 88.9% of dialysis patients developed antibodies against the virus compared to 17.8% of transplant recipients. (Source: the Mail online | Health)
Source: the Mail online | Health - June 9, 2021 Category: Consumer Health News Source Type: news

Medicare's Penalties for Poor-Quality Dialysis Centers Aren't Helping: Study
WEDNESDAY, June 9, 2021 -- Dialysis centers hit with financial penalties for poor performance don't tend to improve afterward, calling into question a set of U.S. federal programs intended to improve health care nationwide, a new report... (Source: Drugs.com - Daily MedNews)
Source: Drugs.com - Daily MedNews - June 9, 2021 Category: General Medicine Source Type: news

Factors ID'd for COVID-19 Infection Risk in Dialysis Patients
TUESDAY, June 8, 2021 -- For individuals receiving in-center hemodialysis, the risk for having a positive test for infection or admission with suspected COVID-19 is associated with age, diabetes, local community COVID-19 rates, and dialysis unit... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 8, 2021 Category: Pharmaceuticals Source Type: news

Financial Penalties for Dialysis Centers Do Not Increase Performance
THURSDAY, June 3, 2021 -- Performance-based financial penalties against outpatient dialysis centers under the End-Stage Renal Disease Quality Incentive Program (ESRD QIP) do not improve performance scores, according to a study published online May... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 3, 2021 Category: Pharmaceuticals Source Type: news

Kenya: Kenyatta Singles Out Dialysis Machines, Renal Units as Jubilee Success
[Nation] The government of Kenya procured 360 dialysis and 48 renal units in the last six years, eight times the number his predecessors had during their administrations, President Uhuru Kenyatta said. (Source: AllAfrica News: Health and Medicine)
Source: AllAfrica News: Health and Medicine - June 3, 2021 Category: African Health Source Type: news

Transplant Referral Less Likely For Dialysis Patients at For-Profit Facilities
WEDNESDAY, June 2, 2021 -- For patients with kidney failure initiating dialysis, referral for evaluation at a transplant center is lower at for-profit facilities, according to a study published online May 26 in the Clinical Journal of the American... (Source: Drugs.com - Pharma News)
Source: Drugs.com - Pharma News - June 2, 2021 Category: Pharmaceuticals Source Type: news

For-Profit Dialysis Patients Miss Out on Transplant Referral For-Profit Dialysis Patients Miss Out on Transplant Referral
For-profit dialysis patients are less likely to be referred for transplant evaluation than patients dialyzed in nonprofit facilities, at least in the Southeastern US.Medscape Medical News (Source: Medscape Medical News Headlines)
Source: Medscape Medical News Headlines - June 1, 2021 Category: Consumer Health News Tags: Nephrology News Source Type: news

Akebia and Otsuka Announce FDA Acceptance for Filing of New Drug Application for Vadadustat for the Treatment of Anemia Due to Chronic Kidney Disease in Adult Patients on Dialysis and Not on Dialysis
CAMBRIDGE, Mass. and TOKYO, June 1, 2021 /PRNewswire/ -- Akebia Therapeutics, Inc. (Nasdaq: AKBA), a biopharmaceutical company with the purpose of bettering the lives of people impacted by kidney disease, and its... (Source: Drugs.com - New Drug Applications)
Source: Drugs.com - New Drug Applications - June 1, 2021 Category: Drugs & Pharmacology Source Type: news

Researchers create machine learning model to predict treatment with dialysis or death for hospitalized COVID-19 patients
(The Mount Sinai Hospital / Mount Sinai School of Medicine) Mount Sinai researchers created a machine learning model to determine COVID-19 patients most at risk for treatment requiring dialysis or critical illness leading to death. (Source: EurekAlert! - Infectious and Emerging Diseases)
Source: EurekAlert! - Infectious and Emerging Diseases - May 28, 2021 Category: Infectious Diseases Source Type: news

Plant-Based Diets Among Patients Undergoing Hemodialysis Plant-Based Diets Among Patients Undergoing Hemodialysis
Could hemodialysis patients safely adhere to a plant-based diet while avoiding complications and meeting their nutritional needs?Nephrology Dialysis Transplantation (Source: Medscape Today Headlines)
Source: Medscape Today Headlines - May 27, 2021 Category: Consumer Health News Tags: Nephrology Journal Article Source Type: news